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Aim: This study evaluates types of malaria and treatment success in a series of identified cases among individuals who were presumed
to have travelled to regions where malaria is endemic.
Materials and methods: In Sema Hospital, 25 cases of malaria (5 in women, 20 in men) were diagnosed during the 6-year period
between 2006 and 2012. The mean age of the patients was 34.5 years. Diagnoses were established with thick and thin peripheral blood
smears that were parasite-positive. These tests were then compared to the rapid diagnostic test based on Plasmodium falciparum
histidine-rich protein 2.
Results: All cases demonstrated fever beginning with chills. Three patients had prophylaxis with doxycycline, but all stopped the
prophylaxis early of their own volition. P. falciparum was the parasitic agent in all cases. A regimen of artemisinin and lumefantrine was
administered in 18 of the 25 cases; quinine plus doxycycline was given in 3, and chloroquine was administered in the remaining 4. Usage
of these regimens cured all cases of malaria without complications.
Conclusion: The importance of prophylaxis of malaria was demonstrated. Malaria should also be included in the differential diagnosis
of patients with fever that have a history of travel to endemic regions.
Key words: Plasmodium falciparum, chemoprophylaxis, rapid tests

1. Introduction
Malaria, which is 1 of the 3 globally most important
infectious diseases according to the World Health
Organization (WHO), is endemic in many areas of the
world and responsible for 2,000,000 deaths each year (1,2).
According to the data collected by the Ministry of Health
of Turkey, Plasmodium vivax is endemic in southeastern
Turkey and other types of Plasmodium sporadically surface
in other regions while P. falciparum is rare (1). Following
the earnest battle against malaria that began in 1926, there
has been a strong reduction in the number of cases over
time. Specifically, there were 14,791 cases of malaria in
1926, 1263 in 1970, and 84 in 2009 (1).
The gold standard of diagnosis in malaria is thick
and thin peripheral blood smears. Serology, molecular
biologic methods, rapid antigen tests, and quantitative
buffy coat blood parasite detection tests are defined as
indirect diagnostic methods (3). Additional difficulties and
differences in the diagnosis and treatment of P. falciparum
malaria are present because of the parasite’s relative rarity
in Turkey. This is why we decided to evaluate the clinical
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and epidemiological features of our 25 serial cases,
identifying the causative pathogen for each.
2. Materials and methods
In this study, 25 malaria patients that presented with fever,
sweating, headache, diarrhea, fatigue, and nausea to our
Infectious Disease Department between January 2006
and September 2012 were diagnosed through the use of
appropriate tests.
All patients were hospitalized for the treatment.
The epidemiological and clinical features such as use
of prophylaxis, impact of specific causative pathogen on
diagnosis, treatment, and response to treatment were
evaluated retrospectively. Thick and thin peripheral
blood smears were prepared from all obtained samples,
and Giemsa stains were taken for evaluation using a light
microscope for diagnosis; this diagnosis was then compared
with that from the immunochromatographic card test
for P. falciparum (P.F. Check 1, Veda Laboratory). A
complete blood count, liver and kidney function tests, and
prothrombin time test were run for all cases.
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3. Results
Of the 25 patients, 5 were female and 20 were male; the
mean age was 34.5 with a range of 18 to 50 years. All
patients had thick and thin peripheral blood smears done
to reveal the presence of malaria; smears were evaluated as
positive for P. falciparum due to erythrocyte morphology.
Of these, 88% of the positive tests (22 patients) yielded
a positive result with the rapid diagnostic test based on P.
falciparum histidine-rich protein 2 (PfHRP2). All patients
had a history of recent travel to sub-Saharan African
countries that are endemic for malaria (Niger, Nigeria,
Burkina Faso, Republic of the Congo, and Tanzania).
Of all the cases, 80% were diagnosed between July and
September 2012. Among the patients, 96% presented with
fever that was typical for malaria, 88% had a daily fever,
48% had nausea and vomiting, 92% had headache, and
20% had diarrhea.
The other clinical findings were thrombocytopenia
( 44%), liver dysfunction ( 28%), splenomegaly (80%),
hepatomegaly (60%), leukopenia (28%), prolonged
prothrombin time (24%), and anemia ( 40%). Three
patients who entered the study had undergone
prophylaxis with doxycycline but t h e n stopped of
their own accord. The responsible parasitic agent was P.
falciparum in all cases. Artemisinin and lumefantrine was
administered in 18 cases; quinine and doxycycline were
administered in 3 cases, and chloroquine was given in the
remaining 4 cases. One patient who did not respond to
treatment with chloroquine was switched to the quinine
and doxycycline regimen. Fresh frozen plasma and
thrombocyte suspensions were each used in 3 cases. The
mean duration of hospitalization was 6.4 days, and all
cases were resolved without any complications from the
selected treatment regimens.
4. Discussion
Malaria has been endemic in many regions of the world
for many years. In Turkey, many soldiers who served in
the Ottoman Army died during the First World War
due to malaria. After the foundation of the Republic of
Turkey in 1923, the scourge of malaria was aggressively
confronted, and cases have diminished in number and
consequence over time, as noted earlier (1). In Turkey, P.
vivax is common, while P. falciparum and P. malariae are
rare. In a study from an Antalya group, 14% of cases
were attributable to P. falciparum and 86% were due to P.
vivax (4). P. vivax was also endemic in another study. It
is remarkable that P. falciparum was responsible for all the
cases of malaria in our study and, furthermore, that it had
been acquired during overseas travel in all cases. Other
cases of P. falciparum in Turkey were also determined to
have originated overseas (5,6).

The diagnosis of malaria was established very easily
and quickly with thick and thin peripheral blood smears
(3,5) The purpose of establishing a diagnosis of malaria
with Giemsa staining of peripheral thick and thin blood
smears was to determine if schizogony or gametocytes of P.
vivax were present in erythrocytes through the appearance
of trophozoites or gametocytes of P. falciparum. WHO
offers 2 types of rapid tests for malaria. One of them
determines PfHRP2 and has 96% sensitivity with 99%
specificity. The other test determines P. falciparum‐
specific lactate dehydrogenase (LDH) activity and pan‐
Plasmodium LDH; it is less sensitive (80%) than PfHRP2,
but more specific (98%) (6,7). In our laboratory, there is
88% sensitivity with PfHRP2, as opposed to 100% with
the Giemsa stain method. We offer rapid tests that keep
treatment from being delayed in instances where it is
impossible to undergo the thick and thin peripheral blood
smear testing, or when one cannot connect with a malaria
control center.
In our study, 80% of patients were men, and all patients
studied were older than 18 years of age. These demographic
statistics were similar to those present in other studies in
Turkey (1,4,5,6). Traveling due to employment can help
explain the male, middle-aged majority.
Malaria can appear in every season in Turkey, but
it is common from May to November. Most of our cases
were found from July to September, again similar to what
was shown in other studies. Özbilgin et al. demonstrated
an elevated incidence during the May–October period
(1). Studies performed in Antalya, Diyarbakır, Bursa,
and Manisa during different time periods also showed
the highest incidence of malaria in summer and autumn
(4–6). This incidence is likely because people travel
abroad more often during summer. In a world marked
by more global travel, many of those who return to Turkey
after traveling in Africa manifest malaria due to the
incubation period of 14–30 days. Sometimes, symptoms
appear abroad and require treatment that starts in the
country of travel and continues in Turkey.
The most important symptom of acute malaria is
periodic episodes of high fever with chills (5,7). The
febrile episodes could begin with or without nonspecific
prodromal symptoms; these symptoms include headache,
loss of appetite, fatigue, myalgia, arthralgia, diarrhea,
nausea, abdominal pain, or sore throat, reminiscent of
many viral infections. To provide a general sense of the
frequency of these symptoms, patients with malaria have
fever with chills in about 80% of cases; additionally, they
frequently experience gastrointestinal symptoms (30%),
fatigue (30%), loss of appetite (20%), and myalgia/arthralgia
(20%) (5,7). In another study, Mert et al. presented a set
of cases of malaria in which 95% of patients presented
with fevers with chills, 50% with headaches, and 45%
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with nausea and diarrhea (4). Finally, İnan et al. showed
100% incidence of fever with chills, 90% incidence of
fatigue, 87.5% incidence of headache, 17.5% incidence of
arthralgia, and 12.5% incidence of diarrhea (5). Our series
of cases had similar incidence for these symptoms: 96%
with episodes of fever and chills, 40% with headache, and
68% with gastrointestinal symptoms.
The details of some of these prodromal symptoms and
other clinical findings can be summarized as follows.
Fever: Fever may not develop periodically in the first
stage of P. vivax and P. falciparum infection. Fever as high
as 40–41 °C is intermittent. Febrile episodes occurring
once every other day signify P. vivax or P. ovale, while
occurrence once every third day is typical of P. malariae
and once every 1–2 days is P. falciparum. Daily fever was
found in 88% of our cases.
Splenomegaly: The increased size of the spleen is
the most important sign of malaria and a benchmark
that allows determination of the duration of disease.
Splenomegaly is present in between 11.5% and 97% of
cases of malaria (5,7) and was shown in 91% of cases by
Mert et al., 72.5% of cases by İnan et al., and 80% of cases
in our study (4,5).
Hepatomegaly: Hepatomegaly was shown in 50% of
patients with malaria by Mert et al. in a series of cases
obtained in İstanbul, in 45% of patients by Inan et al.,
and in 60% in our study (4,5).
Blood-cell abnormalities (anemia, leucopenia,
thrombocytopenia): Anemia and leukopenia, mostly with
thrombocytopenia and (rarely) pancytopenia, can aid in
the diagnosis of malaria (5). Studies of those with malaria
revealed that half of the patients presented with anemia,
20% with leukopenia, and 70% with thrombocytopenia
(5,7). This is roughly aligned with the findings of our
study, in which 45% of the patients had thrombocytopenia,
28% had leukopenia, 12% had pancytopenia, and 40% had
anemia.
Parasitemia: P. falciparum can cause a high degree
of parasitemia (more than 5%) because it is capable of

infecting erythrocytes of all ages. It can also cause severe
complications such as deep anemia, cerebral malaria, acute
kidney failure, acute pulmonary edema, hypoglycemia,
lactic acidosis, and death in the absence of effective
treatment (5,7). Mortality is 1% in P. falciparum-related
malaria (5), but all of the patients were cured in our cases.
There is a wide variety of treatment options for
malaria, some of which are more effective with specific
pathogens. Chloroquine is offered in oral treatment of
P. vivax, P. ovale, P. malariae, and chloroquine-sensitive
P. falciparum (2). Atovaquone-proguanil, artemetherlumefantrine, quinine sulfate and doxycycline, and oral
mefloquine are offered by WHO in East African and
Central African countries due to the high resistance of
P. falciparum to chloroquine (2). Quinidine gluconate,
quinine dihydrochloride, or artemether are choices in
parenteral treatment. Chloroquine is the first choice
in prophylaxis of malaria (P. vivax, P. ovale, P. malariae,
and chloroquine-sensitive P. falciparum) because it can
also be used during pregnancy. Mefloquine, doxycycline,
chloroquine and proguanil, or atovaquone and proguanil
are other choices in prophylaxis of chloroquine-resistant P.
falciparum (2,7).
In Turkey, malaria treatment is implemented and
coordinated by the Ministry of Health of Turkey’s
Malaria Control Center. Treatment was applied through
the guidance of this department in our study.
In conclusion, malaria should be considered in the
differential diagnosis in every case of fever if the patient
has a history of travel to an endemic area, a tropical
country, S outheast Anatolia or the Çukurova area in
Turkey. Prophylaxis of malaria is under the control of the
Border and Coast Directorship of Turkey’s Ministry of
Health. Every country should fulfill its duty and collaborate
in the global battle against malaria, and every citizen should
inform himself or herself about malaria prophylaxis and
about barrier methods against the mosquito before
traveling to endemic areas and be willing to participate in
malaria surveillance efforts after travel.
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